Tuberculosis (ISSN 1873-281X, 1472-9792) is a journal published by Elsevier in the United Kingdom. It covers Immunology and Microbiology, Medicine, Infectious Diseases and Microbiology (medical). It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 2.9, Scopus Q2, Web of Science Q3, CiteScore 4.3 and HEC W-Category. Article processing charge: USD 2,980. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Journal title
Tuberculosis
ISSN
1873-281X, 1472-9792
Subject area
Immunology and MicrobiologyMedicineInfectious DiseasesMicrobiology (medical)ImmunologyMicrobiology
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q2
WoS Quartile
Q3
Impact Factor
2.9
Country
United Kingdom
Publisher
Elsevier
SJR
0.671
Open access
No
APC (USD)
2980
About the journal
Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis. Tuberculosis aims to publish original research and reviews. It publishes articles on host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism. Submissions on bacteriological, immunological and pathogenesis aspects of the disease are particularly welcomed. The journal publishes topics including: • Clinical Trials • Diagnostics • Antimicrobial resistance • Immunology • Leprosy • Microbiology, including microbial physiology • Molecular epidemiology • Non-tuberculous Mycobacteria • Pathogenesis & Pathology • Vaccine development Please note Tuberculosis does not consider: submissions with a meta-analytical focus (e.g., articles based on searches of published articles in public electronic databases will not be considered, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). articles reporting the reanalysis of published data sets to generate hypotheses where there is lack of evidence of the personal involvement of authors in the generation of such material, and where no attempt has been made to test hypotheses experimentally will not be considered. case report submissions or clinical case studies. Submit manuscripts of this type to the companion journals IDCases and Clinical Microbiology Newsletter. articles reporting in silico drug discovery and molecular modelling will not be considered without experimental work to demonstrate meaningful insight into the activity of the series under investigation; further biological evaluation of the mechanism of action, cytotoxicity and potential for drug development is encouraged. Review articles that do NOT offer novel perspectives or insight into a topic and are NOT of general interest to the readership of the journal, or have been covered recently elsewhere, will not be considered.
Aims and Scope
Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis. Tuberculosis aims to publish original research and reviews. It publishes articles on host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism. Submissions on bacteriological, immunological and pathogenesis aspects of the disease are particularly welcomed. The journal publishes topics including: • Clinical Trials • Diagnostics • Antimicrobial resistance • Immunology • Leprosy • Microbiology, including microbial physiology • Molecular epidemiology • Non-tuberculous Mycobacteria • Pathogenesis & Pathology • Vaccine development Please note Tuberculosis does not consider: submissions with a meta-analytical focus (e.g., articles based on searches of published articles in public electronic databases will not be considered, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). articles reporting the reanalysis of published data sets to generate hypotheses where there is lack of evidence of the personal involvement of authors in the generation of such material, and where no attempt has been made to test hypotheses experimentally will not be considered. case report submissions or clinical case studies. Submit manuscripts of this type to the companion journals IDCases and Clinical Microbiology Newsletter. articles reporting in silico drug discovery and molecular modelling will not be considered without experimental work to demonstrate meaningful insight into the activity of the series under investigation; further biological evaluation of the mechanism of action, cytotoxicity and potential for drug development is encouraged. Review articles that do NOT offer novel perspectives or insight into a topic and are NOT of general interest to the readership of the journal, or have been covered recently elsewhere, will not be considered.
Yes. The catalogue records Tuberculosis in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Tuberculosis indexed in Scopus?
Yes. Tuberculosis is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 4.3. Check its current status on the Scopus Sources page.
Is Tuberculosis in Web of Science?
Yes. Tuberculosis is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q3. Confirm on Clarivate's Master Journal List.
What is the impact factor of Tuberculosis?
The recorded journal impact factor of Tuberculosis is 2.9. Clarivate updates impact factors every year in Journal Citation Reports.
Is Tuberculosis open access, and what does it charge?
Tuberculosis is not recorded as fully open access and its APC is USD 2,980. Fees change, so check the journal's website before you submit.
Who publishes Tuberculosis?
Tuberculosis is published by Elsevier in United Kingdom, under ISSN 1873-281X and 1472-9792.
Research profile
2,437articles indexed
78,690citations
114h-index
2.622-year mean citedness
1969first year indexed
Main research topics: Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, Mycobacterium research and diagnosis, Immune responses and vaccinations, Bacterial Genetics and Biotechnology, Diagnosis and treatment of tuberculosis.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.